Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
Hundreds contact BBC about mystery skin condition ‘hell’ – but doctors can’t agree it exists
A Growing Dilemma in Dermatology
Two weeks ago, a BBC News article sparked widespread discussion about a severe and widely debated skin condition linked to social media. Known as topical steroid withdrawal (TSW), the condition has left many patients questioning their treatment. While some see it as an intense eczema flare-up, others argue it’s a distinct illness. The debate has left healthcare professionals divided, and the issue has drawn thousands of responses from readers.
The story of Bethany Norman, a 36-year-old mother, highlights the personal stakes. With her baby son wrapped in bandages, she refused steroid creams after witnessing their effects on her own body. “Look at what this medication has done to me? Why would I apply it to my own son?” she recalls shouting, describing her skin as a battlefield of open wounds and unrelenting itching.
“I’ve been told by countless medics that all I have is a severe flare up of eczema and steroid creams will sort it. They just made it worse.” – Bethany Norman
For years, steroid creams have been a cornerstone of eczema treatment. From mild over-the-counter hydrocortisone to prescription-strength variants, these medications have helped millions manage symptoms. However, a growing number of patients claim they’re experiencing adverse reactions, leading to a crisis of confidence in their use.
Patient Perspectives and Medical Uncertainty
Jenna Crosbie, a trainee GP in north Wales, found herself grappling with this dilemma. She initially struggled to understand why a patient would reject steroids, especially after seeing what she describes as the most severe eczema case she’d encountered. But her own skin began to mirror that condition, prompting her to rethink her approach.
“I remember thinking it looked like the most severe full-body eczema I’d ever seen, and I couldn’t understand why the patient was refusing steroids.” – Jenna Crosbie
Crosbie’s experience illustrates a shift in perspective. After noticing her symptoms diverged from typical eczema, she stopped using topical steroids. Her GP supported this decision, helping her navigate the confusion. “I wouldn’t wish it on my worst enemy,” she says, reflecting on the ordeal.
Doctors’ Conflicting Views and Systemic Challenges
Despite their widespread use, steroid creams are not without controversy. Dr. Dean Eggit, a GP in Doncaster, points to a common misstep: relying on quick fixes without exploring underlying causes. “Unfortunately, the beginnings of TSW can look like the original eczema rash in the first place,” he explains. “This creates a risk of perpetuating the condition with continued use.”
The MHRA acknowledged TSW in 2021 as a possible reaction to prolonged steroid use, but it hasn’t classified it as an official medical condition. This lack of formal recognition has fueled tensions, with patients feeling unheard and doctors unsure how to respond. “There can be a breakdown of communication,” says Dr. Pippa Bowes, an urgent care dermatologist in Southampton. “Patients often don’t feel believed, and some medical professionals struggle to grasp the full picture.”
Guidelines and the Path Forward
Medical guidelines, such as those from NICE, suggest a stepwise approach to eczema treatment. Emollients are recommended first, followed by lower-dose steroids, with adjustments made as needed. Yet, this process relies on follow-ups and vigilance, which can be overlooked in busy clinics.
As the debate continues, patients and doctors remain locked in a cycle of uncertainty. For some, the journey to understanding TSW is as painful as the condition itself. With research still evolving, the medical community is left to navigate a growing divide between treatment and perception.
